Description: Principal Analyst Laurie M. Orlov of the Aging in Place Technology Watch will present a roadmap for the technology and ITSS marketplace. She will explore where it has been, what it does best, where it is going, and the challenges it faces. She has been a leading researcher and independent analyst in this field for more than 20 years.

Description: This presentation is a panel discussion, session 107PD, from the 2004 Spring Meeting of the Society of Actuaries, held May 19-21 in Anaheim, CA. Research results from the National Long-Term Care Survey and other surveys of the general elderly population indicate that age-specific morbidity [functional disability] prevalence rates have dropped significantly since 1982. The panelists quantify the nature of the temporal trends in disease morbidity and functional disability, noting that what is really new in this session is looking at the joint impact of changes in disability and mortality. They illustrate the potential impact of these temporal trends on long-term care insurance LTCI pricing and valuation, and provide some guidance as to how this material can be used by LTCI actuaries. Discussion from participants is included. From the Record of Society of Actuaries, Volume 30, No. 1.

Description: This session from the 2003 SOA Spring Meeting discusses the results of the LTC Insurance Experience Study and how to apply to LTC pricing, setting long-term and short-term objectives and communicating the results through preparing and delivering the report. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 55PD.

Description: Predictive Analytics and Epigenetics are two of the most impactful driving forces for the future of healthcare, precision medicine, and insurance. Learn why this is true, how if will change the way our industry operates, and how you can stay viable and contribute to the betterment of humanity while also protecting the actuarial profession from obsolescence. Learn how personalized medicine keying off genetic testing is saving life insurers big dollars. The only limit seems to be testing access for their insureds.

Description: The hybrid Life/LTC and Life / Chronic Illness market is an exciting market that is in its relative infancy. There are many new companies that have just entered, or are considering entering, the hybrid market. Hybrid sales have grown tremendously over the past decade and are still going strong, with annual premium revenue estimated to be above $4 billion per year. The young issue ages for these products, relative to when LTC benefits are paid, means that the claim experience in the industry for these products is still very limited. Additionally, there are many moving parts to these products that present correlated risks and assumptions. The new entrants to the market, limited experience, and the interactions of risks create an environment equipped for vibrant discussions on the product structure, risks, assumptions, and considerations for modeling these hybrid products. The presenters would provide insight into each of these topics through a conceptual discussion, supported by observational data from case study projections and sensitivities.

Description: In this session, morbidity and life expectancy trends are discussed. In addition, a case study in R on how to model the uncertainty associated with incidence of disability, disabled and active deaths and other terminations is presented.

Description: Session 5 of the 1990 Valuation Actuary Symposium is an open forum on the long term health insurance risks. Also discussed is major medical and disability insurances.